<address id="jdfvj"><address id="jdfvj"><nobr id="jdfvj"></nobr></address></address>

    <noframes id="jdfvj"><p id="jdfvj"><dl id="jdfvj"></dl></p>

      <form id="jdfvj"></form>

      <form id="jdfvj"></form>
      <address id="jdfvj"></address>
      <address id="jdfvj"></address>

      <listing id="jdfvj"><listing id="jdfvj"><menuitem id="jdfvj"></menuitem></listing></listing>

      Contact us

      China National Pharmaceutical
      Group Corporation(SINOPHARM)
      Address: No.20 Zhichun
      Road, Haidian District, Beijing, China
      Postal Code: 100191
      Tel:86-10-82287727
      Fax: 86-10-62033332
      Website: http://www.yijiatd.com.cn

       

      Learn more >>

      Sinopharm News

      【Emirates News Agency】UAE Ministry of Health and Prevention announces official registration of inactivated COVID-19 vaccine used in #4Humanity Trials

      Post Time:2020-12-09 [Large Middle Small] View:

      轉自Emirates News Agency:http://www.wam.ae/en/details/1395302893589

      ABU DHABI, 9th December, 2020 (WAM) -- The UAE’s Ministry of Health and Prevention, MOHAP, has announced the official registration of Beijing Institute of Biological Product’s inactivated COVID-19 vaccine in a major step towards combating the global pandemic. The registration of this vaccine is a decision in response to the application from Sinopharm CNBG. The announcement is a significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.

      MOHAP, in collaboration with Department of Health Abu Dhabi, DOH, has reviewed Sinopharm CNBG’s interim analysis of the phase III trials, which shows Beijing Institute of Biological Product’s inactivated vaccine to have 86 percent efficacy against COVID-19 infection. The analysis also shows the vaccine to have 99 percent seroconversion rate of neutralising antibody and 100 percent effectiveness in preventing moderate and severe cases of the disease. Furthermore, the analysis shows no serious safety concerns.

      This vaccine was granted Emergency Use Authorisation, EUA, since September by MOHAP to protect frontline workers most at risk of COVID-19. The UAE is conducting Post Authorisation Safety Study, PASS, and Post Authorisation Efficacy Study, PAES, of its EUA programme. These ongoing studies show similar safety and efficacy profiles as the interim analysis.

      The #4Humanity phase III trials have included 31,000 volunteers across 125 nationalities in the UAE alone. The EUA vaccination programme has effectively safeguarded the UAE frontline workers. MOHAP's official registration of Beijing Institute of Biological Product’s inactivated COVID-19 vaccine leads the way to comprehensively protecting the population and responsibly opening the economy.

      WAM/Binsal AbdulKader

      黄色电影国语完整版 - 视频 - 在线观看 - 影视资讯 - 品爱网